EYEG News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

EY

Volume

593

Loading chart

EY

EYEGAB Corporate Bond ETF

EYEG

Pay with—

Available Balance0.00

EY

AUM

N/A

Volume

593

Yield

4.88%

Chart Financials Earnings News About Dividends Insider Filings

How to Invest in Bonds: A Beginner's GuideThis article provides a beginner's guide to investing in different types of bonds, including municipal, corporate, government, and foreign bonds. It discusses factors to consider when choosing bonds, such as risk tolerance, investment goals, and tax implications. The article also outlines several bond investment strategies for beginners.Benzinga · Oct 1, 2024

Best Penny Stocks to Buy Right Now? 3 to Watch in OctoberInvesting in penny stocks in 2021? Check these three out for next months watchlist The post Best Penny Stocks to Buy Right Now? 3 to Watch in October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Sep 24, 2021

Penny Stocks For Your Biotech Watch List In September 2021Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Sep 15, 2021

4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%Biotech Penny Stocks Surge As Sector Reverses Course The post 4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Sep 14, 2021

EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceWALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announced that EyeGate’s President and Chief Executive Officer, Brian M. Strem, Ph.D., will provide a corporate update and participate in one-on-one investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13-15, 2021.GlobeNewswire Inc. · Sep 9, 2021

EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for the Treatment of Ocular Surface Inflammation-Proof-of-concept study conducted in Austria; Study designed to build upon positive Phase 1 safety data in healthy volunteers-GlobeNewswire Inc. · Sep 8, 2021

Top Penny Stocks You Need to Know About Right NowAre these top penny stocks on your small-caps watchlist The post Top Penny Stocks You Need to Know About Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Aug 20, 2021

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With MerckHere's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV) Alkermes plc (NASDAQ: ALKS) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) (announced FDA approval for label expansion for its Jemperli) Novo Nordisk A/S (NYSE: NVO) Innoviva, Inc. (NASDAQ: INVA) Intuitive Surgical, Inc. (NASDAQ: ISRG) Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Omega Therapeutics, Inc. (NASDAQ: OMGA) (IPOed July 30) Pfizer, Inc. (NYSE: PFE) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) ResMed Inc. (NYSE: RMD) TScan Therapeutics, Inc. (NASDAQ: TCRX) Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) West Pharmaceutical Services, Inc. (NYSE: WST) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 18) Absci Corporation (NASDAQ: ABSI) Achieve Life Sciences, Inc. (NASDAQ: ACHV) Adaptive Biotechnologies Corporation (NASDAQ: ADPT) ADMA Biologics, Inc. (NASDAQ: ADMA) Akouos, Inc. (NASDAQ: AKUS) Angion Biomedica Corp. (NASDAQ: ANGN) Aptinyx Inc. (NASDAQ: APTX) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) AVROBIO, Inc. (NASDAQ: AVRO) Axsome Therapeutics, Inc. (NASDAQ: AXSM) Biomea Fusion, Inc. (NASDAQ: BMEA) BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Catalyst Biosciences, Inc. (NASDAQ: CBIO) Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) Chemomab Therapeutics Ltd. (NASDAQ: CMMB) CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Compass Therapeutics, Inc. (OTC: CMPX) ContraFect Corporation (NASDAQ: CFRX) CymaBay Therapeutics, Inc. (NASDAQ: CBAY) CytomX Therapeutics, Inc. (NASDAQ: CTMX) Epizyme, Inc. ...Benzinga · Aug 19, 2021

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology BusinessHere's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-the-counter pain relief market with its PainShield Relief) Novo Nordisk A/S (NYSE: NVO) Pfizer, Inc. (NYSE: PFE) (submitted initial data for authorization for COVID-19 booster shot and FDA approval for its vaccine for tick-borne encephalitis) Quest Diagnostics Incorporated (NYSE: DGX) ResMed Inc. (NYSE: RMD) (launched AirSense 11, a device designed to treat sleep apnea) West Pharmaceutical Services, Inc. (NYSE: WST) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 16) 23andMe Holding Co. (NASDAQ: ME) 4D pharma plc (NASDAQ: LBPS) Absci Corporation (NASDAQ: ABSI) ABVC BioPharma, Inc. (NASDAQ: ABVC) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Accelerate Diagnostics, Inc. (NASDAQ: AXDX) Achieve Life Sciences, Inc. (NASDAQ: ACHV) Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Adverum Biotechnologies, Inc. (NASDAQ: ADVM) Agile Therapeutics, Inc. (NASDAQ: AGRX) Akoya Biosciences, Inc. (NASDAQ: AKYA) Angion Biomedica Corp. (NASDAQ: ANGN) Applied Genetic Technologies Corporation (NASDAQ: AGTC) Aptinyx Inc. (NASDAQ: APTX) Aptose Biosciences Inc. (NASDAQ: APTO) Aravive, Inc. (NASDAQ: ARAV) Ardelyx, Inc. (NASDAQ: ARDX) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) Assertio Holdings, Inc. (NASDAQ: ASRT) Atai Life Sciences N.V. (NASDAQ: ATAI) Athenex, Inc. (NASDAQ: ATNX) Athira Pharma, Inc. (NASDAQ: ATHA) Avenue Therapeutics, Inc. (NASDAQ: ATXI) AVITA Medical, Inc. (NASDAQ: RCEL) AVROBIO, Inc. (NASDAQ: AVRO) Axsome Therapeutics, Inc. (NASDAQ: AXSM) Aytu Biopharma, Inc. (NASDAQ: AYTU) Baudax Bio, Inc. (NASDAQ: BXRX) Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) Biodesix, Inc. (NASDAQ: BDSX) Biomea Fusion, Inc. (NASDAQ: BMEA) BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Caladrius Biosciences, Inc. (NASDAQ: CLBS) Cellectis S.A. (NASDAQ: CLLS) Celularity Inc. (NASDAQ: CELU) Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) Chemomab Therapeutics Ltd. (NASDAQ: CMMB) CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ContraFect Corporation (NASDAQ: CFRX) Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) Dermata Therapeutics, Inc. (NASDAQ: DRMA) Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) DURECT Corporation (NASDAQ: DRRX) Edgewise Therapeutics, Inc. (NASDAQ: EWTX) Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) Ensysce Biosciences, Inc. (NASDAQ: ENSC) Enveric Biosciences, Inc. (NASDAQ: ENVB) Epizyme, Inc. (NASDAQ: EPZM) Eton Pharmaceuticals, Inc. (NASDAQ: ETON) Evofem Biosciences, Inc. (NASDAQ: EVFM) EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) FibroGen, Inc. (NASDAQ: FGEN) Flexion Therapeutics, Inc. (NASDAQ: FLXN) Freeline Therapeutics Holdings plc (NASDAQ: FRLN) Gain Therapeutics, Inc. (NASDAQ: GANX) Galecto, Inc. (NASDAQ: GLTO) Gemini Therapeutics, Inc. (NASDAQ: GMTX) Genocea Biosciences, Inc. (NASDAQ: GNCA) Genprex, Inc. (NASDAQ: GNPX) GlycoMimetics, Inc. (NASDAQ: GLYC) Harpoon Therapeutics, Inc. (NASDAQ: HARP) Heron Therapeutics, Inc. (NASDAQ: HRTX) HOOKIPA Pharma Inc. (NASDAQ: HOOK) ( Hoth Therapeutics, Inc. (NASDAQ: HOTH) IMARA Inc. (NASDAQ: IMRA) Immunocore Holdings plc (NASDAQ: IMCR) IN8bio, Inc. (NASDAQ: INAB) Indaptus Therapeutics, Inc. (NASDAQ: INDP) InflaRx N.V. (NASDAQ: IFRX) Inhibikase Therapeutics, Inc. (NASDAQ: IKT) Insmed Incorporated (NASDAQ: INSM) Invitae Corporation (NYSE: NVTA) Itamar Medical Ltd. (NASDAQ: ITMR) Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Keros Therapeutics, Inc. (NASDAQ: KROS) Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) Kinnate Biopharma Inc. (NASDAQ: KNTE) Kura Oncology, Inc. (NASDAQ: KURA) Liminal BioSciences Inc. (NASDAQ: LMNL) Lixte ...Benzinga · Aug 17, 2021

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPOHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (NASDAQ: ADGI) (IPOed Aug. 6) Alkermes plc (NASDAQ: ALKS) Bio-Rad Laboratories, Inc. (NYSE: BIO) Candel Therapeutics, Inc. (NASDAQ: CADL) (IPOed July 26) Century Therapeutics, Inc. (NASDAQ: IPSC) (reacted to its second-quarter results) Dynavax Technologies Corporation (NASDAQ: DVAX) Gilead Sciences, Inc. (NASDAQ: GILD) Harvard Bioscience, Inc. (NASDAQ: HBIO) Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Innoviva, Inc. (NASDAQ: INVA) Johnson & Johnson (NYSE: JNJ) Sesen Bio, Inc. (NASDAQ: SESN) Tenaya Therapeutics, Inc. (NASDAQ: TNYA) (IPOed July 30) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 12) ABVC BioPharma, Inc. (NASDAQ: ABVC) (announced its second-quarter results) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Achilles Therapeutics plc (NASDAQ: ACHL) Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) Akero Therapeutics, Inc. (NASDAQ: AKRO) Allogene Therapeutics, Inc. (NASDAQ: ALLO) Alzamend Neuro, Inc. (NASDAQ: ALZN) Aprea Therapeutics, Inc. (NASDAQ: APRE) (announced that FDA imposed clinical hold on lymphoid malignancy study) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) (announced second-quarter results) Atai Life Sciences N.V. (NASDAQ: ATAI) (announced setting up of a subsidiary for studying Salvinorin A for mental health disorders) Axsome Therapeutics, Inc. (NASDAQ: AXSM) Aytu Biopharma, Inc. (NASDAQ: AYTU) Baudax Bio, Inc. (NASDAQ: BXRX) Baxter International Inc. (NYSE: BAX) Biodesix, Inc. (NASDAQ: BDSX) Biomea Fusion, Inc. (NASDAQ: BMEA) Cellectar Biosciences, Inc. (NASDAQ: CLRB) Celularity Inc. (NASDAQ: CELU) Codex DNA, Inc. (NASDAQ: DNAY) CytomX Therapeutics, Inc. (NASDAQ: CTMX) DiaMedica Therapeutics Inc. (NASDAQ: DMAC) (reacted to its second-quarter results) Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) Edgewise Therapeutics, Inc. (NASDAQ: EWTX) Ensysce Biosciences, Inc. (NASDAQ: ENSC) Epizyme, Inc. (NASDAQ: EPZM) Exicure, Inc. (NASDAQ: XCUR) (announced its second-quarter results) EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) FibroGen, Inc. (NASDAQ: FGEN) Flexion Therapeutics, Inc. (NASDAQ: FLXN) Grifols, S.A. (NASDAQ: GRFS) Heron Therapeutics, Inc. (NASDAQ: HRTX) HOOKIPA Pharma Inc. (NASDAQ: HOOK) (reacted to its second-quarter result) Hoth Therapeutics, Inc. (NASDAQ: HOTH) IMARA Inc. (NASDAQ: IMRA) IN8bio, Inc. (NASDAQ: INAB) Incyte Corporation (NASDAQ: INCY) Inhibikase Therapeutics, Inc. (NASDAQ: IKT) iRhythm Technologies, Inc. (NASDAQ: IRTC) Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) Kronos Bio, Inc. (NASDAQ: KRON) Lava Therapeutics B.V. (NASDAQ: LVTX) Liminal BioSciences Inc. (NASDAQ: LMNL) Lumos Pharma, Inc. (NASDAQ: LUMO) MediciNova, Inc. (NASDAQ: MNOV) Moleculin Biotech, Inc. (NASDAQ: MBRX) (reacted to its second-quarter ...Benzinga · Aug 13, 2021

to start trading

EY

EYEGAB Corporate Bond ETF

EYEG

Pay with—

Available Balance0.00

Your PositionYou don't own any EYEG yet.

Related Tickers

Earnings

Dividends

Last · Oct 1Monthly

Amount$0.14

Yield5.09%

Annual$1.71